These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38297870)
1. [Analysis of Delphain lymph node detection rate, metastasis rate and risk factors for metastasis in papillary thyroid adenocarcinoma patients]. Xin Y; Sun X; Shang X; Xu G; Liu Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 38(2):150-154;159. PubMed ID: 38297870 [No Abstract] [Full Text] [Related]
2. Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis. Zhao J; Zhang Y; Zheng X Br J Oral Maxillofac Surg; 2022 Jun; 60(5):635-638. PubMed ID: 35210104 [TBL] [Abstract][Full Text] [Related]
3. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes. Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of Delphian lymph node metastasis in papillary thyroid carcinoma. Oh EM; Chung YS; Lee YD World J Surg; 2013 Nov; 37(11):2594-9. PubMed ID: 23877804 [TBL] [Abstract][Full Text] [Related]
5. The significance of Delphian lymph node in papillary thyroid cancer. Tan Z; Ge MH; Zheng CM; Wang QL; Nie XL; Jiang LH Asia Pac J Clin Oncol; 2017 Oct; 13(5):e389-e393. PubMed ID: 26990889 [TBL] [Abstract][Full Text] [Related]
7. Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients. Zhong H; Zeng Q; Long X; Lai Y; Chen J; Wang Y World J Surg Oncol; 2024 Jun; 22(1):162. PubMed ID: 38907249 [TBL] [Abstract][Full Text] [Related]
8. [The clinical significance of Delphian lymph node metastasis in papillary thyroid cancer]. Zheng GB; Hao SL; Liu XC; Ning JY; Wu GC; Wang D; Li BY; Jiang LX; Song XC; Zheng HT Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Nov; 51(11):842-845. PubMed ID: 27938611 [No Abstract] [Full Text] [Related]
9. Predictive value of the Delphian lymph node in cervical lymph node metastasis of papillary thyroid carcinoma. Yan Y; Wang Y; Liu N; Duan Y; Chen X; Ye B; Yang R; Zhang W; Wang X Eur J Surg Oncol; 2021 Jul; 47(7):1727-1733. PubMed ID: 33632590 [TBL] [Abstract][Full Text] [Related]
10. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules. Chen ML; Xu D; Yan XQ; Xie BJ Asian J Surg; 2023 Jan; 46(1):156-159. PubMed ID: 35277319 [TBL] [Abstract][Full Text] [Related]
11. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma. Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Model Incorporating Clinicopathological Characteristics of Delphian Lymph Node Metastasis Risk Profiles in Papillary Thyroid Cancer. Li X; Duan Y; Liu D; Liu H; Zhou M; Yue K; Shuai Y; Wang Y; Ji C; Jing C; Wu Y; Wang X Front Endocrinol (Lausanne); 2021; 12():591015. PubMed ID: 33841323 [TBL] [Abstract][Full Text] [Related]
13. Prediction Model of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma. Chen H; Zhu L; Zhuang Y; Ye X; Chen F; Zeng J Cancer Control; 2024; 31():10732748241295347. PubMed ID: 39425895 [TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid carcinoma located in the isthmus or upper third is associated with Delphian lymph node metastasis. Chai YJ; Kim SJ; Choi JY; Koo do H; Lee KE; Youn YK World J Surg; 2014 Jun; 38(6):1306-11. PubMed ID: 24366273 [TBL] [Abstract][Full Text] [Related]
15. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC? Ma W; Guo Y; Hua T; Li L; Lv T; Wang J Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400 [TBL] [Abstract][Full Text] [Related]
16. Significance of multifocality in papillary thyroid carcinoma. Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090 [TBL] [Abstract][Full Text] [Related]
17. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level. Liu WQ; Yang JY; Wang XH; Cai W; Li F BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785 [TBL] [Abstract][Full Text] [Related]
18. Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma. Sun H; Zhao X; Wang X; Ma J; Liu M Diagn Pathol; 2024 Jan; 19(1):13. PubMed ID: 38218832 [TBL] [Abstract][Full Text] [Related]
19. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis. Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253 [TBL] [Abstract][Full Text] [Related]
20. Use of Delphian lymph node metastasis to predict central and lateral involvement in papillary thyroid carcinoma: A systematic review and meta-analysis. Huang J; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T Clin Endocrinol (Oxf); 2019 Jul; 91(1):170-178. PubMed ID: 30851206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]